PAGLIARULO, CLORINDO
 Distribuzione geografica
Continente #
NA - Nord America 250
EU - Europa 106
AS - Asia 101
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 462
Nazione #
US - Stati Uniti d'America 243
SG - Singapore 42
CN - Cina 33
IT - Italia 32
NL - Olanda 27
HK - Hong Kong 22
DE - Germania 13
FI - Finlandia 13
CA - Canada 7
IE - Irlanda 6
UA - Ucraina 5
BE - Belgio 4
CI - Costa d'Avorio 4
IN - India 3
SE - Svezia 3
GB - Regno Unito 2
EU - Europa 1
IR - Iran 1
RU - Federazione Russa 1
Totale 462
Città #
Chandler 39
Singapore 36
Amsterdam 26
Hong Kong 22
Millbury 22
Ashburn 17
Jacksonville 16
Santa Clara 15
Princeton 13
Naples 12
Houston 10
Nanjing 9
Beijing 7
Ottawa 7
Changsha 4
Hasselt 4
Wilmington 4
Shenyang 3
Lanzhou 2
Napoli 2
Abidjan 1
Ardabil 1
Bangalore 1
Boston 1
Genova 1
Hebei 1
Hengyang 1
Kunming 1
Milan 1
Moscow 1
Norwalk 1
Pune 1
Rome 1
San Giuseppe Vesuviano 1
San Mateo 1
Seattle 1
Shanghai 1
Tianjin 1
Totale 288
Nome #
A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer. 49
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. 45
Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) Study. 42
Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifen. 40
Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study. 38
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study). 37
Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients. 34
Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer. 34
Effect of adjuvant tamoxifen and CMF on endocrine function of patients with operable breast cancer. 32
CA 15-3 in human breast cancer. Comparison with tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA). 31
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study. 31
Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer. 31
Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximated genetic subtypes. 30
Totale 474
Categoria #
all - tutte 2.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.568


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 0 0 0 0 0 4 4 15
2020/202126 5 1 4 1 1 5 1 0 1 0 7 0
2021/202281 2 0 0 0 0 2 0 1 7 10 26 33
2022/2023121 13 5 4 2 18 7 0 14 25 26 6 1
2023/202471 1 17 12 7 2 11 0 8 0 0 4 9
2024/202590 16 20 0 1 11 17 25 0 0 0 0 0
Totale 474